TBVI

(redirected from Tuberculosis Vaccine Initiative)
AcronymDefinition
TBVITuberculosis Vaccine Initiative (Netherlands)
TBVITotal Blood Volume Index
References in periodicals archive ?
Since the 1980s, Maurice was associated with the South African Tuberculosis Vaccine Initiative and was instrumental in the establishment of the clinical trial site in Worcester--now the largest in the world--where he mentored many clinicians.
This Phase IIb study was sponsored by Aeras and conducted by the University of Cape Town's South African Tuberculosis Vaccine Initiative (SATVI).
The South African Tuberculosis Vaccine Initiative (SATVI) is an academic research unit within the University of Cape Town (UCT) that has been involved in clinical TB research for over 10 years.
There are 12 different vaccines in clinical trials, but this is the most advanced," said Michele Tameris who manages the trial at the South African Tuberculosis Vaccine Initiative (SATVI) site.
Dr Jelle Thole, Director of TuBerculosis Vaccine Initiative (TBVI) stressed upon the need to develop safe vaccines that can be used in HIV exposed positive children as the existing BCG vaccine, being a live vaccine, is not safe in HIV infected children.
All authors are current or previous lead investigators at the South African Tuberculosis Vaccine Initiative (SATVI), Faculty of Health Sciences, University of Cape Town.
This was a much-heard statement during the annual research meeting of the TuBerculosis Vaccine Initiative (TBVI).
South African Tuberculosis Vaccine Initiative, Institute of Infectious Diseases and Molecular Medicine, University of